Home
About
Publications Trends
Recent Publications
Expert Search
Archive
eml4 alk fusion
What Types of Cancer are Associated with EML4-ALK Fusion?
EML4-ALK fusion is predominantly associated with a subset of NSCLC, occurring in approximately 3-7% of cases. It is also observed in other malignancies, albeit less frequently, such as
anaplastic large cell lymphoma
and
inflammatory myofibroblastic tumors
.
Frequently asked queries:
What is EML4-ALK Fusion?
How Does EML4-ALK Fusion Occur?
What Types of Cancer are Associated with EML4-ALK Fusion?
Who is at Risk for EML4-ALK Positive Cancers?
How is EML4-ALK Fusion Detected?
What is the Prognosis for Patients with EML4-ALK Positive Cancers?
What Are the Symptoms of Motion Sensitivity in Cancer Patients?
What Impact Does Access to Healthcare Have on Cancer Inequities?
What Strategies Exist to Prevent Cardiotoxicity in Cancer Patients?
What Are the Limitations of Saliva Samples?
What Are Some Challenges When Using PubMed?
What types of cancers are studied by the ICGC?
Are There Any Risks Associated with Expanding the Field of View?
What are the Future Directions for Microarray Data in Cancer Research?
How is the Best Treatment Determined?
Can Lifestyle Changes Impact Cancer Risk for BRCA Mutation Carriers?
What Should Patients Ask Their Doctors?
How Do Healthcare Providers Monitor Immunocompromised Cancer Patients?
What are the Limitations of Cancer Cell Lines?
Are There Any Risks Associated with Using Cooling Gels?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Nanotechnology
Non-Hodgkin’s Lymphoma
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
CIAbimatoprost
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
diffuse large B-cell lymphoma
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
Keratinocyte
Lipid-based nanoparticles
liver cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
radiotherapy
refractory lymphoma
relapsed lymphoma
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe